Ignite Creation Date:
2024-05-05 @ 11:28 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00042952
Status:
TERMINATED
Last Update Posted:
2013-01-17
First Post:
2002-08-05
Brief Title:
Imatinib Mesylate in Treating Patients With Progressive Refractory or Recurrent Stage II or Stage III Testicular or Ovarian Cancer
Sponsor:
Organization:
National Cancer Institute NCI